Literature DB >> 28110566

[The current situation of cancer morbidity and mortality in the light of the National Cancer Registry].

Miklós Kásler1, Szabolcs Ottó1, István Kenessey1.   

Abstract

In a previous issue of this journal the authors presented and summarized the basic objectives and tasks of the Hungarian National Cancer Registry positioned in an international environment. The recent publication is a continuation of the previous one. Based on the presentation and analysis of current statistical data, the public health background with the possible risk factors is examined. Considering changes in recent years, the mortality data are relatively stable, although slightly wavering. The trends are promising in some cancers (for example lip and oral cavity, breast, prostate cancers) however. Contrary to the barely changing nature of the total cancer deaths the number of annually reported new cases has increased significantly, which indicates a more effective role in both diagnostics and therapy. In light of the above, it is confirmed that the restructure of the national oncology care system and the European conformation is inevitable. Orv. Hetil., 2017, 158(3), 84-89.

Entities:  

Keywords:  cancer morbidity and mortality; international comparison; nemzetközi összehasonlítás; népegészségügyi jelentőség; rákmorbiditás és -mortalitás; significance of public health

Mesh:

Year:  2017        PMID: 28110566     DOI: 10.1556/650.2017.30654

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Short- and Long-Term (10-year) Results of an Organized, Population-Based Breast Cancer Screening Program: Comparative, Observational Study from Hungary.

Authors:  Dezső Tóth; Zsolt Varga; Judit Tóth; Péter Árkosy; Éva Sebő
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

2.  Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells.

Authors:  Lei Zhang; Hongmei Chen; Mingfei Wang; Xiaojing Song; Fanghui Ding; Jun Zhu; Xun Li
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.